Speaking fluently with baclofen?

BMJ Case Reports
Esther BerahaReinout Wiers

Abstract

Baclofen is a new and promising pharmacological compound for the treatment of alcohol dependence (AD). Although several randomised trials found a reduction of craving and higher abstinence rates with low and high doses of baclofen, others failed to show positive effects. In this case study, the successful treatment of a patient with AD with daily 120 mg of baclofen is described. In addition to a decrease in alcohol use, we observed the cessation of stuttering during treatment with baclofen, reoccurrence of stuttering following discontinuation, and cessation of stuttering after reinstatement of the treatment. Based on this observation, the direct effects of baclofen on muscle relaxation and anxiety reduction and its indirect effect on dopaminergic inhibition, we believe that baclofen might be a new treatment for stuttering. Further research into the effect of baclofen on stuttering is warranted.

References

Feb 10, 1997·Neuroreport·J C WuA Najafi
Sep 16, 1998·Journal of Pain and Symptom Management·P WalkerE Bruera
Feb 3, 2000·Alcoholism, Clinical and Experimental Research·G ColomboG L Gessa
Sep 10, 2002·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Giovanni AddoloratoGiovanni Gasbarrini
Apr 2, 2003·Psychopharmacology·Giancarlo ColomboGian Luigi Gessa
Dec 15, 2004·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Olivier Ameisen
Dec 15, 2004·Alcoholism, Clinical and Experimental Research·Barbara A FlanneryAmy Trivette
Dec 19, 2006·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·William Bucknam
Aug 28, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·George F Koob, Nora D Volkow
Jul 29, 2010·Alcoholism, Clinical and Experimental Research·James C GarbuttBarbara A Flannery
Sep 24, 2014·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·K C MorleyP S Haber
Jun 7, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Christian A MüllerAndreas Heinz
Sep 12, 2015·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·E M KrupitskyN G Neznanov
Nov 16, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Esther M BerahaReinout W Wiers

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Psychopharmacology
Adam PastorJon Currie
Annales médico-psychologiques
J M Leger, G Daudet
The Journal of Clinical Psychiatry
R S Salem, C E Muniz
The British Journal of Psychiatry : the Journal of Mental Science
J W Lovett
© 2022 Meta ULC. All rights reserved